[Clinical management of asymptomatic HCV carriers].
Nakamura
Ikuo
I
Division of Gastroenterology, Omiya Medical Center, Jichi Medical School.
Ochiai
Kaori
K
Imawari
Michio
M
D000410:Alanine Transaminase / Q000097:blood; D000998:Antiviral Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D002353:Carrier State / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D000075202:Contraindications; D004359:Drug Therapy, Combination; D005355:Fibrosis; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008099:Liver / Q000473:pathology; D017410:Practice Guidelines as Topic; D012254:Ribavirin / Q000627:therapeutic use
D000998:Antiviral Agents; D015415:Biomarkers; D012254:Ribavirin; D007372:Interferons; D000410:Alanine Transaminase